Other Vaccines - Estonia

Estonia

Highlights

In Estonia, the revenue in the Other Vaccines market is forecasted to reach US$12.34m in 2024.
This market is expected to display an annual growth rate (CAGR 2024-2029) of 10.55%, leading to a market volume of US$20.38m by 2029.
When compared globally, United States is projected to generate the highest revenue in this market, amounting to US$24.73bn in 2024.
Estonia is experiencing a growing demand for other vaccines as the government focuses on promoting preventive healthcare measures.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other Vaccines market in Estonia has been developing steadily over the years, driven by various factors such as customer preferences, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Estonians have a strong preference for preventative healthcare, which has increased the demand for vaccines. Moreover, the country has a well-established vaccination program, which has led to a high vaccination rate among the population. This has created a positive perception of vaccines, including other vaccines, among Estonians.

Trends in the market: The Other Vaccines market in Estonia has been experiencing steady growth due to the increasing demand for vaccines. This growth is supported by the government's efforts to promote vaccination through public awareness campaigns and vaccination programs. Additionally, the market has been expanding due to the introduction of new vaccines that offer protection against various diseases.

Local special circumstances: Estonia has a small population, which has led to a limited market size for vaccines. However, the country has a high vaccination rate, which has created a positive perception of vaccines among the population. Moreover, the government has been actively promoting vaccination through public awareness campaigns and vaccination programs, which has increased the demand for vaccines, including other vaccines.

Underlying macroeconomic factors: Estonia has a strong economy, which has supported the growth of the Other Vaccines market. The country has a well-developed healthcare system, which has made vaccines accessible to the population. Additionally, the government has been investing in healthcare infrastructure, which has improved the delivery of healthcare services, including vaccination services. These factors have contributed to the growth of the Other Vaccines market in Estonia.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.